Valuation Takeda Pharmaceutical Company Limited

Stocks

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange 02:30:00 2026-10-19 EDT			5-day change	1st Jan Change
6,244.00 ^JPY	+0.34%		+6.86%	+29.14%

11:58am	Takeda Pharmaceutical Company Limited Announces New Data From VERDICT Showing Treating Adults With Intravenous ENTYVIO To Achieve Corticosteroid-Free Disease Clearance Prolongs Time To First Ulcerative Colitis-Related Complication	CI
09:43am	Pharma sector doubles down on AI to slash costs, timelines	RE

Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	5,423,454	6,762,204	6,564,378	6,749,675	8,948,061	9,970,162	-	-
Change	-	24.68%	-2.93%	2.82%	32.57%	11.42%	-	-
Enterprise Value (EV) ¹	8,919,170	10,611,015	10,950,330	10,725,175	5,130,461	13,877,231	13,674,281	13,369,554
Change	-	18.97%	3.2%	-2.06%	-52.16%	170.49%	-1.46%	-2.23%
P/E	23.8x	21.3x	45.4x	64.6x	46.4x	49.5x	31.4x	25.6x
PBR	0.95x	1.06x	0.9x	1x	1.2x	1.34x	1.34x	1.33x
PEG	-	0.5x	-0.8x	-2.5x	0.6x	14.56x	0.5x	1.1x
Capitalization / Revenue	1.52x	1.68x	1.54x	1.47x	1.99x	2.12x	2.08x	2.03x
EV / Revenue	2.5x	2.63x	2.57x	2.34x	1.14x	2.95x	2.85x	2.72x
EV / EBITDA	8.54x	9.19x	11.6x	9.71x	4.54x	10.8x	9.87x	9.25x
EV / EBIT	19.4x	21.6x	51.1x	31.3x	12.6x	29.5x	22.7x	19.1x
EV / FCF	8.92x	28.7x	43.4x	15.5x	8.14x	19.7x	19.5x	18.2x
FCF Yield	11.2%	3.49%	2.31%	6.43%	12.3%	5.08%	5.13%	5.5%
Dividend per Share ²	180	180	188	196	200	204.3	208.4	215.8
Rate of return	5.15%	4.14%	4.49%	4.44%	3.53%	3.27%	3.34%	3.46%
EPS ²	147.1	204.3	92.09	68.36	122	126.1	198.8	244.1
Distribution rate	122%	88.1%	204%	287%	164%	162%	105%	88.4%
Net sales ¹	3,569,006	4,027,478	4,263,762	4,581,600	4,505,700	4,703,826	4,794,279	4,922,149
EBITDA ¹	1,043,995	1,154,905	942,077	1,103,982	1,129,888	1,283,280	1,384,870	1,445,085
EBIT ¹	460,844	490,505	214,100	342,600	408,800	469,702	603,380	698,554
Net income ¹	230,059	317,017	144,067	107,900	191,800	196,254	322,799	383,827
Net Debt ¹	3,495,716	3,848,811	4,385,952	3,975,500	-3,817,600	3,907,070	3,704,120	3,399,392
Reference price ²	3,498.00	4,350.00	4,184.00	4,413.00	5,664.00	6,244.00	6,244.00	6,244.00
Nbr of stocks (in thousands)	1,550,444	1,554,530	1,568,924	1,529,498	1,579,813	1,596,759	-	-
Announcement Date	5/11/22	5/11/23	5/9/24	5/8/25	5/13/26	-	-	-

¹JPY in Million²JPY

Estimates

P/E, Detailed evolution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TAKEDA PHARMACEUTICAL COMPANY LIMITED	49.25x	2.94x	10.78x	3.28%	62.94B
ELI LILLY AND COMPANY	35.96x	12.96x	27.14x	0.55%	1,120B
JOHNSON & JOHNSON	37.4x	6.3x	17.74x	2.09%	616B
ABBVIE INC.	36.43x	8.36x	17.24x	2.43%	504B
ROCHE HOLDING AG	20.46x	4.99x	12.38x	2.64%	367B
MERCK & CO., INC.	106.52x	5.95x	25.12x	2.33%	360B
NOVARTIS AG	21.18x	5.54x	13.63x	2.88%	288B
ASTRAZENECA PLC	21.7x	4.38x	12.55x	2.01%	258B
AMGEN INC.	27.46x	7.06x	12.64x	2.33%	234B
GILEAD SCIENCES, INC.	-45.63x	6.99x	27.07x	2.11%	194B
Average	31.07x	6.55x	17.63x	2.27%	400.38B
Weighted average by Cap.	34.95x	8.12x	19.89x	1.86%